Recent advancements in non-invasive diagnostics, including real-time biometric monitoring, enable healthcare providers to detect diseases without relying on invasive techniques like blood tests. By utilizing sensors and algorithms, diseases can be predicted and prevented through faster early detection.
The use of imaging for diagnostics in healthcare dates back a long period. The advent of modern technology has led to tremendous advancements over the last 50 years. With this technology, an unimaginable pool of data can be gathered from multiple imaging modalities in a structured format, providing detailed information on the internal organs of the human body.
Now, imagine a scenario where you know exactly what is happening within your body at any point in time with the help of biometric data, capturing key indicators of your health and wellness.
Patients with specific health conditions or even healthy individuals looking to keep track of key parameters can highly benefit from the advancements happening in non-invasive diagnosis with real-time biometric monitoring. For example, recently, there has been growing interest in the use of exhaled breath analysis as a non-invasive diagnostic tool for respiratory disorders, including asthma.
Advancements in noninvasive technology have enabled remote diagnostics to become real. However, telehealth and telemedicine solutions can serve a wider purpose only if noninvasive real-time diagnostics become a reality. This technology not only makes healthcare more affordable and accessible, but it also promotes better health outcomes through predictive care.
The invisible radio frequencies are everywhere. At the molecular level, from hydrogen and oxygen to cholesterol and carbohydrates, all have a unique frequency fingerprint. Any device that can detect and convert molecular fingerprints into biometrics can help diagnose underlying diseases. For example, a sensor can check blood glucose levels to monitor what is going on inside the body.
A sensor can be deployed in a wellness device such as a wristband or fitness watch for treating and managing a health condition. Sensor technology can enable real-time, painless, and remote diagnosis while supporting the telehealth boom and solving typical challenges including distance, transportation, and scheduling issues.
When longitudinal data is combined with algorithms and artificial intelligence, it can predict serious diseases and help prevent them due to early-stage detection. Also, it can provide timely intervention for various health conditions resulting in reduced insurance premiums with the help of early condition detection.
Recently, many innovations have happened in blood glucose monitoring, and many medical equipment manufacturers are developing devices in the noninvasive diagnosis space. Moreover, minimally invasive devices for glucose monitoring are already in the market and widely used. However, an affordable and accurate solution with noninvasive technology can revolutionize the healthcare industry.
On the noninvasive imaging side, technology has been targeted towards the structure and function of tissues and organs. Using Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasound (US) scans, a series of structural images can be produced that show the morphology and anatomy of a given body part.
Multiple imaging techniques provide molecular-level information on physiology. For diagnostics, functional imaging is more important as it provides vital data regarding the functioning of a tissue or an organ. Some examples of functional imaging techniques include CT, MRI, and US scanning.
For everyone to have access to risk-based cancer diagnosis and prevention, it is important to reduce the financial and social burden of this disease. As non-invasive cancer diagnostic techniques continue to improve detection accuracy, the global market is expected to expand in the coming years. To achieve this, major players in non-invasive cancer diagnostics are making significant investments to enhance their diagnostic capabilities.
The global market for non-invasive cancer diagnostics was worth US$ 104.8 billion in 2021. According to projections, the market is expected to grow at a Compound Annual Growth Rate (CAGR) of 7% during the forecast period of 2022 to 2031. By 2031, the value of the non-invasive cancer diagnostics market is predicted to exceed US$ 207 billion.
eInfochips has worked on an FDA Class II non-invasive diagnostic solution that transforms the way healthcare services are provided. We developed a solution for our client that provides remote healthcare service support to examine various health parameters, including skin, heart, lungs, ears, and body temperature.
Moreover, eInfochips developed a platform to share and store a data repository, including live video streams and analytics over the cloud. Also, the client was looking to develop handheld devices with sensors that detect various body conditions. eInfochips has helped the customer develop a medical device that detects and monitors various physical parameters by leveraging medical device engineering capabilities.
With the progress made in the noninvasive diagnostic space, in the recent future, technological advancements are expected to enable the monitoring and identification of various health indicators beyond glucose. FDA regulations ensure that technology is safe and effective by accessing the processes with high-level scrutiny and making it go through a rigorous testing cycle.
With eInfochips’ proven technological expertise in modern medical devices, including non-invasive diagnostics, a myriad of healthcare use cases can be served. It can also help enhance the efficiency of clinical trials with biometric sensor technology as it can detect the potential of any side effects.
